drug · Product Intelligence

Placebo Oral Tablet
Pipeline Intelligence

Placebo Oral Tablet: 11 indexed trials, 9 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
11Indexed trials
▦
9Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT01862640Otsuka Pharmaceutical Development & Commercialization, Inc. · alzheimersPHASE3
NCT02348606Jazz Pharmaceuticals · other_neurologyPHASE3
NCT03020797Stony Brook University · alsNA
NCT03234686Neuroscience Trials Australia · alzheimersPHASE2
NCT03489044University of Oxford · alzheimersPHASE2
NCT03511599University of Calgary · depressionPHASE1
NCT03515733University of Oxford · depressionPHASE1
NCT04053036University of Chicago · autismEARLY_PHASE1
NCT04079803Cassava Sciences, Inc. · alzheimersPHASE2
NCT05395494University of Calgary · pain_neuropathyPHASE2
NCT06563895Eidos Therapeutics, a BridgeBio company · alzheimersPHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.